Back to top
more

Avinger (AVGR)

(Delayed Data from NSDQ)

$0.78 USD

0.78
79,430

0.00 (0.00%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $0.79 +0.01 (1.28%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (79 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Sanghamitra Saha headshot

5 Top-Ranked Rising P/E Stocks to Lure Investors

Inside the top-ranked stocks that have been exhibiting rising P/E ratios.

    Align Technology (ALGN) Beats on Q1 Earnings and Revenues

    Align Technology Inc. (ALGN) reported adjusted earnings per share (EPS) of 85 cents in the first quarter of 2017, up 70% from 50 cents posted in the year-ago quarter.

      Cerner (CERN) Earnings and Revenues Beat Estimates in Q1

      Cerner Corp (CERN) reported adjusted first-quarter 2017 earnings of 56 cents per share, beating the Zacks Consensus Estimate of 53 cents.

        CONMED (CNMD) Q1 Earnings Surpass Estimates, Increase Y/Y

        CONMED Corporation (CNMD) reported first-quarter 2017 adjusted earnings of 38 cents per share, beating the Zacks Consensus Estimate by 4 cents.

          Stryker (SYK) Earnings and Revenues Beat Estimates in Q1

          Stryker Corp (SYK) reported adjusted earnings of $1.48 per share in the first quarter of 2017, which comfortably beat the Zacks Consensus Estimate by 5 cents.

            Centene (CNC) Beats Q1 Earnings on HealthNet Acquisition

            Centene Inc. (CNC) reported first-quarter 2017 adjusted net income per share of $1.12 cents, which beat the Zacks Consensus Estimate by 5.7%.

              Merit Medical (MMSI) Closes 5.2M Follow-On Share Offering

              Merit Medical Systems, Inc. (MMSI) announced that it has closed its follow-on public offering of 5.2 million shares of common stock at $28.25 per share.

                Akers Receives Cholesterol Test Kit Order from First Check

                Akers Biosciences, Inc. (AKER) announced that it has received an initial order under the distribution agreement for its rapid cholesterol self-test kit.

                  Henry Schein (HSIC) Poised on Solid Growth, Risks Remain

                  On Mar 27, we issued an updated research report on Melville, NY-based Henry Schein, Inc. (HSIC).

                    BioScrip (BIOS) Stock Declines on Dull Q1 EBITDA Outlook

                    Bioscrip, Inc.'s (BIOS) shares witnessed a 2.2% fall in yesterday's trading session, closing at $1.78.

                      Evolent Health (EVH) Prices 7.5M Follow-On Share Offering

                      Evolent Health, Inc. (EVH) announced the pricing of its follow-on public offering of 7.5 million shares of Class A common stock at $21.25 per share.

                        LifePoint Grows Inorganically Yet Stock Suffers: Here's Why

                        Despite its efforts to grow inorganically, LifePoint's shares returned 15.2% compared with a 31% gain for the Zacks categorized Medical Hospital industry over the past three years.

                          DexCom Gains as CMS Announces Criteria for G5 Mobile CGM

                          The Centers for Medicare & Medicaid Services published an article clarifying the criteria for coverage of its DexCom (DXCM) G5 Mobile CGM system for patients with diabetes and on intensive insulin therapy.

                            Medidata Clinical Cloud Selected for AML Master Trial by LLS

                            Medidata Solutions Inc. (MDSO) announced that The Leukemia & Lymphoma Society selected Medidata Clinical Cloud platform for diagnosis and treatment of acute myeloid leukemia (AML) through a clinical trial known as the Beat AML Master Trial.

                              The Cooper Companies Hits 52-Week High on Multiple Positives

                              Shares of Pleasanton, CA-based The Cooper Companies (COO) rallied to a new 52-week high of $202.70 on Mar 23, closing a tad lower at $199.70.

                                Merit Medical (MMSI) Prices 4.5M Follow-On Share Offering

                                Merit Medical Systems, Inc. (MMSI) announced that it has priced its follow-on public offering of 4.5 million shares of common stock at $28.25 per share.

                                  Should HCA Holdings (HCA) Stock Be in Your Portfolio Now?

                                  HCA Holdings Inc. (HCA) stock has gained 8.12% in the last one year, outperforming the Zacks categorized Medical-Hospitals industry, which registered an increase of only 1.26%.

                                    Cooper Companies (COO) Increase Share Repurchase Program

                                    The Cooper Companies, Inc. (COO) recently announced that it has approved a $500.0 million increase in its ongoing share repurchase program.

                                      WellCare Health's Revenue Growth Strong, Rising Costs a Drag

                                      WellCare Health Plans, Inc. (WCG) stock has long been an investor favorite owing to strong fundamentals.

                                        HealthEquity (HQY) Q4 Earnings and Revenues Beat Estimates

                                        HealthEquity Inc (HQY) reported earnings of 7 cents per share in the fourth quarter of 2016, higher than the Zacks Consensus Estimate of 5 cents.

                                          DENTSPLY Sirona Grapples with Multiple Issues: Dump Now?

                                          On Mar 20, we issued an updated research report on NY-based DENTSPLY Sirona Inc. (XRAY) -- a global leader in the design, development, manufacture and marketing of dental consumables and dental laboratory products.

                                            Neogen (NEOG) Earnings and Revenues Meet Estimates in Q3

                                            Neogen Corp (NEOG) reported adjusted earnings of 27 cents per share in the third quarter of fiscal 2017. The figure was in line with the Zacks Consensus Estimate and increased 22.7% from the year-ago quarter.

                                              Merit Medical (MMSI) to Refinance Debt via Share Offering

                                              Merit Medical Systems, Inc. (MMSI) announced that it has commenced a follow on public offering of its common stock.

                                                Mazor Robotics-Medtronic's Mazor X Partnership Strengthens

                                                Mazor Robotics (MZOR) recently announced that its strategic partnership with Medtronic Plc. (MDT) for the commercialization and co-promotion of Mazor X platform, an innovative guidance system for spine surgery, is going strong.

                                                  Fresenius (FMS) to Jointly Develop Acumen with Epic Systems

                                                  Fresenius Medical Care AG & Co. KGAA (FMS) announced that it would jointly develop Acumen 2.0 with Epic Systems Corporation.